Adding targeted therapy to treatment extends lives of those with metastatic breast cancer

(MediaSource) A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news